v3.25.2
Shareholders’ Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 6 Months Ended
May 27, 2025
Apr. 01, 2025
Mar. 31, 2025
Mar. 25, 2025
Jan. 30, 2025
Jan. 13, 2025
Jun. 30, 2025
May 30, 2025
Dec. 31, 2024
Shareholders’ Equity [Line Items]                  
Proceeds from issuance of private placement (in Dollars)     $ 17,000            
Shares issued [1]             5,880,763   16,778
Warrant exercise price (in Dollars per share)             $ 0.00001    
Ordinary shares, authorized [1]             2,000,000,000   79,582
Ordinary shares, par value (in Dollars per share)                
Ordinary shares ratio one-for-250           1:250    
Period for increment in reverse stock split             18 months    
Number of warrants or rights agreed to be exchanged     15,705            
Number of warrants to be issued upon exchange     15,705            
Warrants liability (in Dollars)             $ 70  
Finance expense (in Dollars)             3,139    
Ordinary held share 250                
Restricted stock units granted fair value (in Dollars)             $ 585    
Pre-Funded Warrants [Member]                  
Shareholders’ Equity [Line Items]                  
Number of warrants exercised       660 800        
Shares issuable for each warrant exercisable             1    
Series A Warrants [Member]                  
Shareholders’ Equity [Line Items]                  
Warrants             141,667    
Warrant exercise price (in Dollars per share)             $ 300    
Warrants exercisable term             30 months    
Warrants liability (in Dollars)             $ 14,752    
Warrants issued recognized value (in Dollars)             2,248    
Warrant [Member]                  
Shareholders’ Equity [Line Items]                  
Proceeds issuance costs (in Dollars)             1,903    
Warrants issuance costs (in Dollars)             1,652    
Additional paid in capital (in Dollars)             $ 251    
Exchange Warrants [Member]                  
Shareholders’ Equity [Line Items]                  
Shares issuable for each warrant exercisable             15,705    
Ordinary Shares [Member]                  
Shareholders’ Equity [Line Items]                  
Number of warrants exercised             5,720,542 5,720,542  
Ordinary shares issued       660 800        
Ordinary Shares [Member] | Series A Warrants [Member]                  
Shareholders’ Equity [Line Items]                  
Shares issued             8,984    
Restricted Stock Units (RSUs) [Member]                  
Shareholders’ Equity [Line Items]                  
Grant options           1,582      
Ordinary Units [Member] | Series A Warrants [Member]                  
Shareholders’ Equity [Line Items]                  
Components of unit, number of warrants             1    
Ordinary Units [Member] | Ordinary Shares [Member]                  
Shareholders’ Equity [Line Items]                  
Components of unit, number of shares             1    
Right of warrant, number of shares to be purchased             1    
Pre-Funded Unit [Member] | Pre-Funded Warrants [Member]                  
Shareholders’ Equity [Line Items]                  
Components of unit, number of warrants             1    
Pre-Funded Unit [Member] | Series A Warrants [Member]                  
Shareholders’ Equity [Line Items]                  
Components of unit, number of warrants             1    
Pre-Funded Unit [Member] | Ordinary Shares [Member]                  
Shareholders’ Equity [Line Items]                  
Right of warrant, number of shares to be purchased             1    
Pre-Funded Warrants [Member] | Series A Warrants [Member]                  
Shareholders’ Equity [Line Items]                  
Prefunded Warrants             132,683    
Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member]                  
Shareholders’ Equity [Line Items]                  
Number of share issued           610      
Vesting period           24 months      
Board of Directors Chairman [Member] | Restricted Stock Units (RSUs) [Member]                  
Shareholders’ Equity [Line Items]                  
Number of share issued           600      
Chief Technology Officer [Member] | Restricted Stock Units (RSUs) [Member]                  
Shareholders’ Equity [Line Items]                  
Number of share issued           240      
Vesting period           24 months      
Chief Financial Officer [Member] | Restricted Stock Units (RSUs) [Member]                  
Shareholders’ Equity [Line Items]                  
Number of share issued           20      
Vesting period           36 months      
Company’s Scientific Advisory Board [Member] | Restricted Stock Units (RSUs) [Member]                  
Shareholders’ Equity [Line Items]                  
Vesting period           36 months      
Before Shareholder Approval [Member]                  
Shareholders’ Equity [Line Items]                  
Ordinary shares, authorized             20,000,000    
Ordinary shares, par value (in Dollars per share)                
Private Placement [Member]                  
Shareholders’ Equity [Line Items]                  
Proceeds from issuance of private placement (in Dollars)   $ 17,000              
Proceeds issuance costs (in Dollars)   $ 15,097              
Additional paid in capital (in Dollars)             $ 9    
Finance expense (in Dollars)             1,626    
Private Placement [Member] | Exchange Warrants [Member]                  
Shareholders’ Equity [Line Items]                  
Warrants liability (in Dollars)             $ 1,635    
Private Placement [Member] | Ordinary Units [Member]                  
Shareholders’ Equity [Line Items]                  
Ordinary units     141,667            
Purchase price per unit (in Dollars per share)     $ 120            
Private Placement [Member] | Pre-Funded Warrants [Member]                  
Shareholders’ Equity [Line Items]                  
Purchase price per unit (in Dollars per share)     $ 119.9975            
Minimum [Member] | Board of Directors Chairman [Member] | Restricted Stock Units (RSUs) [Member]                  
Shareholders’ Equity [Line Items]                  
Number of share issued           12      
Vesting period           24 months      
Minimum [Member] | Company’s Scientific Advisory Board [Member] | Restricted Stock Units (RSUs) [Member]                  
Shareholders’ Equity [Line Items]                  
Number of share issued           13      
Maximum [Member] | Board of Directors Chairman [Member] | Restricted Stock Units (RSUs) [Member]                  
Shareholders’ Equity [Line Items]                  
Number of share issued           60      
Vesting period           36 months      
Maximum [Member] | Company’s Scientific Advisory Board [Member] | Restricted Stock Units (RSUs) [Member]                  
Shareholders’ Equity [Line Items]                  
Number of share issued           52      
2021 Plan [Member]                  
Shareholders’ Equity [Line Items]                  
Reserved for issuance           3,200      
Share options outstanding             985    
Placement Agent [Member] | Private Placement [Member]                  
Shareholders’ Equity [Line Items]                  
Percentage of aggregate gross proceeds             10.00%    
Investor [Member] | Pre-Funded Warrants [Member]                  
Shareholders’ Equity [Line Items]                  
Number of warrants exercised             132,683 132,683  
Investor [Member] | Series A Warrants [Member]                  
Shareholders’ Equity [Line Items]                  
Number of warrants exercised             140,833 140,833  
Investor [Member] | Exchange Warrants [Member]                  
Shareholders’ Equity [Line Items]                  
Number of warrants exercised             12,967 12,967  
Investor [Member] | Ordinary Shares [Member]                  
Shareholders’ Equity [Line Items]                  
Number of warrants exercised             132,683 132,683  
Ordinary Shares [Member]                  
Shareholders’ Equity [Line Items]                  
Additional ordinary shares issued 316                
Ordinary Shares [Member] | Securities Purchase Agreement [Member]                  
Shareholders’ Equity [Line Items]                  
Ordinary shares issued 1                
[1] Retroactively adjusted to give effect to the reverse share split, see also note 4b.